ClinicalTrials.gov
public full text
Public Domain
A Pilot Trial of Curcumin Effects on Cognition in Schizophrenia
This is an 8-week randomized, double-blind, placebo-controlled, parallel, fixed-dose pilot clinical trial of curcumin for the treatment of cognitive impairment in schizophrenia.The primary aim of this pilot trial is to provide an effect size estimate for the efficacy of curcumin in improving cognitive functioning in schizophrenia. Secondary goals are to determine the effect of curcumin over time on negative and positive symptoms, in association with inflammatory markers.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of Prebiotic and Probiotic Dietary Modulation in Schizophrenic Disorders#825922
- The Effects of Prebiotics on Cognitive Functioning and Weight Gain in Psychosis#918024
- Withania Somnifera: an Immunomodulator and Anti-inflammatory Agent for Schizophrenia#899494
- Inflammation, childhood trauma, and symptom dimensions in schizophrenia: a path-analysis study#1358610
- Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group#849350
Record · ID 1259175
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive